Table 2.
Baseline characteristics of patients who developed CI-AKI and those who did not
| Demographic | Group of patients who developed CI-AKI (n = 5) |
Group of patients who did not develop CI-AKI (n = 47) |
p value |
|---|---|---|---|
| Male (n, %) | 4 (80%) | 27 (57%) | 0.33 |
| Age (years) | 67.1 ± 8.8 | 60 ± 4.3 | 0.05 |
| BMI | 29.3 ± 2.2 | 29.1 ± 4.3 | 0.94 |
| Hypertension (n, %) | 5 (100%) | 40 (85%) | 0.81 |
| Hypercholesterolemia (n, %) | 1 (20%) | 21 (45%) | 0.56 |
| DM (n, %) | 3 (60%) | 12 (26%) | 0.27 |
| Atrial fibrillation (n, %) | 2 (40%) | 7 (15%) | 0.43 |
| Heart failure (n, %) | 4 (80%) | 22 (47%) | 0.35 |
| Planned coronary angiography (n, %) | 1 (20%) | 11 (23%) | 0.69 |
| Emergency coronary angiography (n, %) | 5 (100%) | 35 (74%) | 0.52 |
| STEMI/NSTEMI (n, %) | 3 (60%) | 7 (15%) | 0.01 |
| UA (n, %) | 2 (40%) | 33 (70%) | 0.39 |
| Arterial stenosis (n, %) | 3 (60%) | 16 (34%) | 0.51 |
| Creatinine (μmol/L) |
81.2 ± 26.4 80.6 (53.6–109.3) |
80.9 ± 19.3 77.1 (67.8–90.2) |
0.49 |
| Baseline GFR |
95.9 ± 32.39 92.8 (63.2–130.2) |
82.0 ± 18.5 83.9 (73.4–93.4) |
0.08 |
| eGFR at admission < 60 mL/min/1.73 m2 (n %) | 0 (0%) | 7 (15%) | 0.97 |
| Contrast volume (ml) | 140 ± 79.3 | 110.8 ± 89.2 | 0.49 |
Bolded values indicate statistical significance
DM diabetes mellitus, CKD chronic kidney disease, STEMI ST elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, UA unstable angina